Bellevue Asset Management (Switzerland)’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-20,000
Closed -$517K 145
2015
Q2
$517K Sell
20,000
-10,000
-33% -$253K 0.07% 127
2015
Q1
$657K Buy
+30,000
New +$648K 0.09% 127

Other funds holding ENTL

Bellevue Asset Management (Switzerland)'s ENTL Position: Q3 2015 in Review

Bellevue Asset Management (Switzerland) sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q3 2015, closing a stake of 20,000 shares — an estimated $517K sold.

Bellevue Asset Management (Switzerland) first reported a position in ENTL in Q1 2015 and held it in 2 quarters. The position peaked at $657K in Q1 2015. 53 funds tracked by Wall St. Rank hold ENTL as of Q3 2015.

  • Bellevue Asset Management (Switzerland) reported no remaining Entellus Medical, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Bellevue Asset Management (Switzerland) sold 20,000 Entellus Medical, Inc. Common Stock shares in Q3 2015, an estimated $517K.
  • Bellevue Asset Management (Switzerland) first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 2 quarters.
  • Bellevue Asset Management (Switzerland)'s Entellus Medical, Inc. Common Stock position peaked at $657K in Q1 2015.
  • 53 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q3 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q3 2015, filed 12 Nov 2015.